6.6-Hour inhalation of ozone concentrations from 60 to 87 parts per billion in healthy humans

Edward S Schelegle, Christopher A. Morales, William F. Walby, Susan Marion, Roblee P Allen

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Rationale: Identification of the minimal ozone (O3) concentration and/or dose that induces measurable lung function decrements in humans is considered in the risk assessment leading to establishing an appropriate National Ambient Air Quality Standard for O3 that protects public health. Objectives: To identify and/or predict the minimal mean O3 concentration that produces a decrement in FEV1 and symptoms in healthy individuals completing 6.6-hour exposure protocols. Methods: Pulmonary function and subjective symptoms were measured in 31 healthy adults (18-25 yr, male and female, nonsmokers) who completed five 6.6-hour chamber exposures: filtered air and four variable hourly patterns with mean O 3 concentrations of 60, 70, 80, and 87 parts per billion (ppb). Measurements and Main Results: Compared with filtered air, statistically significant decrements in FEV1 and increases in total subjective symptoms scores (P , 0.05) were measured after exposure to mean concentrations of 70, 80, and 87 ppb O3. The mean percent change in FEV1 (±standard error) at the end of each protocol was 0.80 6 0.90, -2.72 ± 1.48, -5.34 ± 1.42, -7.02 ± 1.60, and -11.42 ± 2.20% for exposure to filtered air and 60, 70, 80, and 87 ppb O3, respectively. Conclusions: Inhalation of 70 ppb O3 for 6.6 hours, a concentration below the current 8-hour National Ambient Air Quality Standard of 75 ppb, is sufficient to induce statistically significant decrements in FEV 1 in healthy young adults.

Original languageEnglish (US)
Pages (from-to)265-272
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume180
Issue number3
DOIs
StatePublished - Aug 1 2009

Fingerprint

Ozone
Inhalation
Air
Lung
Young Adult
Public Health

Keywords

  • Clinical study
  • Exposure assessment
  • Human
  • Ozone

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

6.6-Hour inhalation of ozone concentrations from 60 to 87 parts per billion in healthy humans. / Schelegle, Edward S; Morales, Christopher A.; Walby, William F.; Marion, Susan; Allen, Roblee P.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 180, No. 3, 01.08.2009, p. 265-272.

Research output: Contribution to journalArticle

@article{4ac8a33a6d8e4bf8bcddd371042e54c6,
title = "6.6-Hour inhalation of ozone concentrations from 60 to 87 parts per billion in healthy humans",
abstract = "Rationale: Identification of the minimal ozone (O3) concentration and/or dose that induces measurable lung function decrements in humans is considered in the risk assessment leading to establishing an appropriate National Ambient Air Quality Standard for O3 that protects public health. Objectives: To identify and/or predict the minimal mean O3 concentration that produces a decrement in FEV1 and symptoms in healthy individuals completing 6.6-hour exposure protocols. Methods: Pulmonary function and subjective symptoms were measured in 31 healthy adults (18-25 yr, male and female, nonsmokers) who completed five 6.6-hour chamber exposures: filtered air and four variable hourly patterns with mean O 3 concentrations of 60, 70, 80, and 87 parts per billion (ppb). Measurements and Main Results: Compared with filtered air, statistically significant decrements in FEV1 and increases in total subjective symptoms scores (P , 0.05) were measured after exposure to mean concentrations of 70, 80, and 87 ppb O3. The mean percent change in FEV1 (±standard error) at the end of each protocol was 0.80 6 0.90, -2.72 ± 1.48, -5.34 ± 1.42, -7.02 ± 1.60, and -11.42 ± 2.20{\%} for exposure to filtered air and 60, 70, 80, and 87 ppb O3, respectively. Conclusions: Inhalation of 70 ppb O3 for 6.6 hours, a concentration below the current 8-hour National Ambient Air Quality Standard of 75 ppb, is sufficient to induce statistically significant decrements in FEV 1 in healthy young adults.",
keywords = "Clinical study, Exposure assessment, Human, Ozone",
author = "Schelegle, {Edward S} and Morales, {Christopher A.} and Walby, {William F.} and Susan Marion and Allen, {Roblee P}",
year = "2009",
month = "8",
day = "1",
doi = "10.1164/rccm.200809-1484OC",
language = "English (US)",
volume = "180",
pages = "265--272",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - 6.6-Hour inhalation of ozone concentrations from 60 to 87 parts per billion in healthy humans

AU - Schelegle, Edward S

AU - Morales, Christopher A.

AU - Walby, William F.

AU - Marion, Susan

AU - Allen, Roblee P

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Rationale: Identification of the minimal ozone (O3) concentration and/or dose that induces measurable lung function decrements in humans is considered in the risk assessment leading to establishing an appropriate National Ambient Air Quality Standard for O3 that protects public health. Objectives: To identify and/or predict the minimal mean O3 concentration that produces a decrement in FEV1 and symptoms in healthy individuals completing 6.6-hour exposure protocols. Methods: Pulmonary function and subjective symptoms were measured in 31 healthy adults (18-25 yr, male and female, nonsmokers) who completed five 6.6-hour chamber exposures: filtered air and four variable hourly patterns with mean O 3 concentrations of 60, 70, 80, and 87 parts per billion (ppb). Measurements and Main Results: Compared with filtered air, statistically significant decrements in FEV1 and increases in total subjective symptoms scores (P , 0.05) were measured after exposure to mean concentrations of 70, 80, and 87 ppb O3. The mean percent change in FEV1 (±standard error) at the end of each protocol was 0.80 6 0.90, -2.72 ± 1.48, -5.34 ± 1.42, -7.02 ± 1.60, and -11.42 ± 2.20% for exposure to filtered air and 60, 70, 80, and 87 ppb O3, respectively. Conclusions: Inhalation of 70 ppb O3 for 6.6 hours, a concentration below the current 8-hour National Ambient Air Quality Standard of 75 ppb, is sufficient to induce statistically significant decrements in FEV 1 in healthy young adults.

AB - Rationale: Identification of the minimal ozone (O3) concentration and/or dose that induces measurable lung function decrements in humans is considered in the risk assessment leading to establishing an appropriate National Ambient Air Quality Standard for O3 that protects public health. Objectives: To identify and/or predict the minimal mean O3 concentration that produces a decrement in FEV1 and symptoms in healthy individuals completing 6.6-hour exposure protocols. Methods: Pulmonary function and subjective symptoms were measured in 31 healthy adults (18-25 yr, male and female, nonsmokers) who completed five 6.6-hour chamber exposures: filtered air and four variable hourly patterns with mean O 3 concentrations of 60, 70, 80, and 87 parts per billion (ppb). Measurements and Main Results: Compared with filtered air, statistically significant decrements in FEV1 and increases in total subjective symptoms scores (P , 0.05) were measured after exposure to mean concentrations of 70, 80, and 87 ppb O3. The mean percent change in FEV1 (±standard error) at the end of each protocol was 0.80 6 0.90, -2.72 ± 1.48, -5.34 ± 1.42, -7.02 ± 1.60, and -11.42 ± 2.20% for exposure to filtered air and 60, 70, 80, and 87 ppb O3, respectively. Conclusions: Inhalation of 70 ppb O3 for 6.6 hours, a concentration below the current 8-hour National Ambient Air Quality Standard of 75 ppb, is sufficient to induce statistically significant decrements in FEV 1 in healthy young adults.

KW - Clinical study

KW - Exposure assessment

KW - Human

KW - Ozone

UR - http://www.scopus.com/inward/record.url?scp=67749103588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749103588&partnerID=8YFLogxK

U2 - 10.1164/rccm.200809-1484OC

DO - 10.1164/rccm.200809-1484OC

M3 - Article

C2 - 19447899

AN - SCOPUS:67749103588

VL - 180

SP - 265

EP - 272

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -